Skip to main content

Endothelin in Hypertension and Diabetes Mellitus

  • Chapter
The Endothelium in Cardiovascular Disease

Abstract

Diabetes and hypertension are two of the most prevalent chronic diseases afflicting mankind. Individuals with one of these maladies often suffer from the other and it is now increasingly recognized that such concurrence is greater than what would be predicted by chance alone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weidmann P, Ferrari P (1991) Central role of sodium in hypertension in diabetic subjects. Diabetes Care 14: 220ā€“232

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  2. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinnelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N EngI Med 317: 350ā€“357

    Google ScholarĀ 

  3. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595ā€“1607

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  4. Shen DC, Shieh SM, Fuh MMT, Wu D-A, Chen Y-DI, Reaven GM (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580ā€“583

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  5. Tarn AC, Drury PL (1986) Blood pressure in children, adolescent and young adults with type 1 (insulin-dependent) diabetes. Diabetologia 29: 275ā€“281

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  6. Mathieson ER, Ronn B, Jensen T, Storm B, Dechkert T (1990) Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 39: 245ā€“249

    ArticleĀ  Google ScholarĀ 

  7. Norgaar K, Feldt-Rasmussen B, Borch-Jensen K, Saelan H, Deckert T (1990) Prevalence of hypertension in insulin-dependent diabetes mellitus. Diabetologia 33: 407ā€“410

    ArticleĀ  Google ScholarĀ 

  8. Viberti GC (1991) Diabetic nephropathy: links with hypertension and atherosclerosis. Cardiovasc Risk Fact 1: 368ā€“374

    Google ScholarĀ 

  9. Epstein M, Sowers JR (1992) Diabetes mellitus and hypertension. Hypertension 19: 403ā€“418

    PubMedĀ  CASĀ  Google ScholarĀ 

  10. Feldt-Rasmussen B, Mathiesen ER, Decken T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type-1 (insulin-dependent) diabetes mellitus. Diabetologia 30: 610ā€“617

    PubMedĀ  CASĀ  Google ScholarĀ 

  11. Guyton AC (1991) Blood pressure control -special role of the kidneys and body fluids. Science 252: 1813ā€“1816

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  12. Sanchez-Martos J, Gutsowska J, Lopez-Novoa JM, Luque-Otero M, Fernandez M, Diaz Y, Ibarra J, Fernandez-Cruz A (1993) Volume expansion, natriuresis and atrial natriuretic peptide in type I and type II diabetes. Cardiovasc Risk Fact 3: 174ā€“180

    Google ScholarĀ 

  13. Yuan C, Manunta P, Chen S, Hamlyn J, Pamnani M (1992) Hypertension induced by chronic ouabain administration in rats. FASEB J 6: A945

    Google ScholarĀ 

  14. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM (1992) Chronic reversible hypertension in rats induced by ouabain but not digoxin. Hypertension 20: 404 (abstract)

    Google ScholarĀ 

  15. Manunta P, Evans G, Hamilton BP, Gann D, Resau J, Hamlyn JM (1992) A new syndrome with elevated plasma ouabain and hypertension secondary to an adrenocortical tumor. J Hypertens to [Suppl 4]: 527 (abstract)

    Google ScholarĀ 

  16. Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4: 20ā€“34

    PubMedĀ  CASĀ  Google ScholarĀ 

  17. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannin E (1986) Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 62: 1302ā€“1304

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  18. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809ā€“817

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  19. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885ā€“888

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  20. Hall JE, Coleman TG, Mezelle HL, Smith MJ (1990) Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol 258: F722 - F731

    PubMedĀ  CASĀ  Google ScholarĀ 

  21. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246ā€“2252

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  22. Sowers JR, Khoury S, Standley P, Zemel P (1991) Mechanism of hypertension in diabetes. Am J Hypertens 4: 177ā€“182

    PubMedĀ  CASĀ  Google ScholarĀ 

  23. Sowers Jr, Standley P, Jacoper S, Resnick M (1993) Diabetes mellitus and hypertension: the double whammy. Cardiovasc Risk Fact 3: 164ā€“169

    Google ScholarĀ 

  24. Anderson E, Mark A (1993) Cardiovascular and sympathetic actions of insulin: the insulin hypothesis of hypertension revisited. Cardiovasc Risk Fact 3: 159ā€“163

    Google ScholarĀ 

  25. Kramer HJ, Meyer-Lehnert H, Michel H, Predel H (1991) Endogenous natriuretic and ouabain-like factors: their roles in body fluid volume and blood pressure regulation. Am J Hypertens 4: 81ā€“89

    PubMedĀ  CASĀ  Google ScholarĀ 

  26. Furchgott RF (1990) Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand 139: 257ā€“270

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  27. Kamata K, Miyata N, Kasuya Y (1989) Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614ā€“618

    PubMedĀ  CASĀ  Google ScholarĀ 

  28. Harris KH, MacLeod KM (1988) Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153: 55ā€“64

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  29. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S (1989) Endothelin binding to cultured calf adrenal zona glomerulose cells and stimulation of aldosterone secretion. J Clin Invest 84: 1032ā€“1035

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  30. Boarder MR, Marriott DB (1988) Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromattin cells. J Cardiovasc Pharmacol 13 [Suppl 5]: S233ā€“5224

    Google ScholarĀ 

  31. Vierhapper H, Wagner O, Nowotny P, WaldhƤusl W (1990) Effect of endothelin 1 in man. Circulation 81: 1415ā€“1418

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  32. Ohno A, Naruse M, Kato S, Hosaka M, Naruse K, Demura H (1992) Endothelin-specific antibodies decrease blood pressure and increase glomerular filtration rate and renal plasma flow in spontaneously hypertensives rats. J Hypertens 10: 781ā€“785

    Google ScholarĀ 

  33. Nishikibe M, Ikada M, Tsuchida S, Fukuroda T, Shimamoto K, Kobayashy M, Ishikawa K, Yano M, Ikemoto F (1992) Antihypertensive effect of a newly synthesized endothelin antagonist, BO-123, in genetic hypertension models. J Hypertens 10 [suppl 4]: P53

    Google ScholarĀ 

  34. Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Loeffler BM, Mueller M, Neidhart W, Ramuz H (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365: 759ā€“761

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  35. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T (1990) Plasma immunoreactive endothelin in essential hypertension. Am J Med 88: 654

    ArticleĀ  Google ScholarĀ 

  36. Lƶscher TF, Seo BG, Bhuler FR (1993) Controversy on endothelin in hypertension. Hypertension 21: 752ā€“757

    Google ScholarĀ 

  37. Myauchi T, Yanagisawa M, Suzuki N, Iida K, Sugishita Y, Fujino M, Saito T, Goto K, Masaki T (1989) Venous plasma concentrations of endothelin in normal and hypertensive subjects (abstract). Circulation 8o [Suppl II]: II - 2280

    Google ScholarĀ 

  38. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ (1990) A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 78: 261

    PubMedĀ  CASĀ  Google ScholarĀ 

  39. Schrader J, Teebe U, Borries M, Ruschitzka F, Schoel G, Kandt M, Warneke G, Zurchner C, Weber MH, Neu U, Rath W, Henning HV (1990) Plasma Endothelin bei normalen Personen and Patienten mit nephrologisch-rheumatologischen and kardiovaskularen Erkrankungen. Klin Wochenschr 68: 774

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  40. Schiffrin EL, Thibahult G (1991) Plasma endothelin in human essential hypertension. Am J Hyper-tens 4: 303

    CASĀ  Google ScholarĀ 

  41. Shihiri M, Mirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inque A, Marumo F (1990) Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 55: 493

    Google ScholarĀ 

  42. Saito Y, Nakao K, Mukoyama M, Shirakami G, Ito H, Yamada T, Arai H, Hosoda K, Suga S, Jougasaki M, Ogawa Y, Nakajima S, Veda M, Imura H (1990) Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 55: 734

    Google ScholarĀ 

  43. Noth RH, Lassman N, Tan SY, Fernandez-Cruz A, Mulrow PJ (1977) Age and the renin-aldosterone system. Arch Intern Med 137: 1414ā€“1417

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  44. Fernandez-Cruz A, Martin P, Fernandez L, Sanchez J, Ibarra J, Moya J, Fernandez-Durango R, Gonzalez G, Martell N, Fernandez-Pinilla C, Luque Otero M (1993) Plasma endothelin is increased in young essential hypertensives but not in elderly essential nor in diabetic hypertensives. J Hypertension 11 [Suppl 5]: 8146ā€“8147

    ArticleĀ  Google ScholarĀ 

  45. Takahashi K, Ghatei M. A, Lam H.C, Oā€™Halloran DJ, Bloom SR (1990) Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 33: 306ā€“310

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  46. Kawamura M, Ohgawara H, Naruse M, Suziki N, Iwasaki N (1992) Increase plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 15: 1396ā€“1399

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  47. Collier A, Leach JP, Mclellan A, Jardine A, Morton JJ, Small M (1992) Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 8: 1038ā€“1040

    ArticleĀ  Google ScholarĀ 

  48. Lee YJ, Shin SJ, Tsai JH (1994) Increased urinary endothelin-s-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 4: 263ā€“266

    ArticleĀ  Google ScholarĀ 

  49. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sondberg SM, Burnett JC Jr (1991) Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 321: 997ā€“1001

    ArticleĀ  Google ScholarĀ 

  50. Patifo F, Ibarra J, Molino A, Fernandez-Durango R, Moya J, Fernandez-Cruz A (1994) Increased plasma endothelin in diabetes: an atherosclerosis marker? Diabetologia 37: 334

    Google ScholarĀ 

  51. Haak T, Jungmann E, Felber A, Hillmann U, Henning K (1992) Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5: 161ā€“166

    PubMedĀ  CASĀ  Google ScholarĀ 

  52. de Juan JA, Moya J, Garcia de la Cova M, Fernandez-Durango R, Fernandez-Cruz A (1993) Identification and characterization of endothelin receptor subtype ( ETb) in rat retina. J Neurochem 61: 1113ā€“1119

    Google ScholarĀ 

  53. Stewart DJ, Kubac G, Costello KB, Cernacek P (1991) Increased plasma endothelin 1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18: 38

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  54. Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Fernandez-Cruz A (1994) High plasma levels of endothelin 1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 7: 1085ā€“1089

    PubMedĀ  CASĀ  Google ScholarĀ 

  55. Omland T, Lie RT, Aakvaag A, Arsland T, Dickstein K (1994) Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89: 1573ā€“1579

    PubMedĀ  CASĀ  Google ScholarĀ 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fernandez-Cruz, A. et al. (1995). Endothelin in Hypertension and Diabetes Mellitus. In: LĆ¼scher, T.F. (eds) The Endothelium in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79803-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79803-0_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79805-4

  • Online ISBN: 978-3-642-79803-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics